Multiple system atrophy – Life with Disease

Go back

Multiple system atrophy is a rare and progressive neurological condition that affects movement, balance, and many of the body’s automatic functions like blood pressure and bladder control. Understanding what lies ahead can help patients and families prepare for the challenges this disease brings.

Understanding the Outlook for Multiple System Atrophy

When someone receives a diagnosis of multiple system atrophy, one of the first questions that often comes to mind is about the future and what to expect. This is a deeply personal and understandably difficult topic, but having clear information can help patients and their loved ones make informed decisions about care and quality of life.[1]

Multiple system atrophy is, unfortunately, a progressive disease, which means that symptoms gradually worsen over time. The disease typically affects adults in their 50s or 60s, though symptoms can begin anywhere from the late 40s to early 70s. From the time symptoms first appear, the disease tends to advance relatively quickly compared to other similar conditions.[2]

Research shows that the estimated survival time from when symptoms begin ranges from six to eleven years, with the median survival being approximately nine and a half years. However, this timeline can vary considerably from person to person depending on the severity of symptoms and which body systems are most affected. Some individuals may experience a slower progression, while others may face more rapid deterioration.[3][8]

The disease is ultimately fatal, and this is an important reality for patients and families to understand. Most people with multiple system atrophy will eventually need mobility aids such as a cane or walker within just a few years after symptoms begin. As the condition advances, individuals typically require increasing levels of assistance with daily activities and eventually become bedridden.[2][3]

⚠️ Important
While the prognosis for multiple system atrophy is serious, it’s important to remember that each person’s journey with this disease is unique. Some individuals may live longer than average estimates, and advances in symptom management can significantly improve quality of life during the time patients have. Open conversations with healthcare providers about goals of care can help ensure that treatment aligns with individual values and preferences.

How the Disease Progresses Without Treatment

Understanding the natural course of multiple system atrophy helps patients and families anticipate what changes may occur. When left without any symptom management or supportive care, the disease follows a predictable pattern of deterioration that affects multiple body systems simultaneously.[1]

The disease typically begins with subtle symptoms that might not immediately raise concern. Many people first notice problems with their autonomic nervous system, which is the body’s internal system that controls involuntary functions. This might manifest as difficulty controlling blood pressure when standing up quickly, leading to dizziness or lightheadedness. Bladder problems, such as increased urgency or frequency, are also common early signs. Men may experience erectile dysfunction as an early symptom.[4]

As months and years pass, movement problems become more apparent. These can take different forms depending on which type of multiple system atrophy a person has. Some individuals develop symptoms similar to Parkinson’s disease, including slow movement, muscle stiffness, and sometimes tremors. Others primarily experience problems with coordination and balance, leading to a staggering, unsteady gait that might resemble being intoxicated.[1][2]

The progression continues to affect more body systems. Speech often becomes slurred, slow, or very soft, making communication increasingly challenging. Swallowing difficulties can develop, which creates risks for choking and aspiration. Vision changes may occur, including blurred or double vision. Many people experience problems with temperature regulation, either feeling too hot or too cold when others are comfortable.[1]

Over time, the deterioration of brain areas that control these functions becomes more severe. The basal ganglia, structures near the center of the brain that help coordinate movement, progressively lose function. The brainstem, which manages automatic processes like breathing and heart rate, also deteriorates. The cerebellum, responsible for coordinating movements and balance, becomes increasingly damaged.[3]

Without intervention, individuals eventually lose the ability to walk independently and require full-time care for basic daily activities. Severe autonomic dysfunction can lead to dangerous drops in blood pressure, breathing abnormalities during sleep, and difficulty regulating body temperature. The progressive nature of the disease means that functions continue to decline steadily until the person becomes completely dependent on others for care.[5]

Potential Complications That May Arise

Multiple system atrophy brings with it a range of complications that can significantly impact health and safety. These unexpected developments often require medical attention and can sometimes be more immediately dangerous than the primary symptoms themselves.[1]

One of the most serious complications is orthostatic hypotension, which is a sudden and significant drop in blood pressure when standing up. This isn’t just a minor inconvenience—it can cause complete loss of consciousness without warning. The main danger here is the risk of falls and the injuries that can result from them. Falls can lead to broken bones, head injuries, and other trauma that can further reduce mobility and independence. Some people with this condition may faint so suddenly that they don’t have time to catch themselves or sit down safely.[4]

Swallowing problems, known medically as dysphagia, represent another significant complication. When the muscles involved in swallowing don’t work properly, food or liquid can go down the wrong pipe and enter the lungs instead of the stomach. This can lead to aspiration pneumonia, a type of lung infection that develops when foreign material enters the airways. In the later stages of multiple system atrophy, aspiration pneumonia becomes one of the most common and serious complications, and it can be life-threatening.[2]

Sleep-related breathing problems can also emerge. Many people with multiple system atrophy develop noisy breathing, unintentional sighing, or sleep apnea, where breathing repeatedly stops and starts during sleep. These breathing irregularities can reduce oxygen levels in the blood and disrupt sleep quality, leading to extreme daytime fatigue and other health problems.[1][4]

Muscle and joint complications can develop as well. Some individuals experience contractures, which is a chronic shortening of muscles or tendons around joints that prevents the joints from moving freely. This makes movement even more difficult and can be painful. Others develop unusual posture problems such as Pisa syndrome, where the body leans involuntarily to one side, or anterocollis, where the neck bends forward and the head drops down.[2]

Mental health complications are also important to recognize. Anxiety and depression are common in people with multiple system atrophy. While some of this relates to the emotional impact of living with a serious illness, changes in the brain itself may also contribute to mood problems. Additionally, some people develop unpredictable episodes of laughing or crying that don’t match their actual emotions.[1]

Another complication involves the bladder and bowel. Beyond the frequent need to urinate, people may lose complete control of bladder function, requiring the use of catheters or absorbent products. Severe constipation is also common and can become quite uncomfortable if not properly managed.[3]

Impact on Daily Life and Activities

Living with multiple system atrophy affects virtually every aspect of daily life, from the most basic self-care tasks to work, hobbies, and social relationships. Understanding these impacts can help patients and families plan ahead and find ways to maintain quality of life despite the challenges.[14]

Physical activities become progressively more difficult as the disease advances. Simple tasks that most people take for granted—like getting dressed, preparing meals, or bathing—may require extra time and effort, and eventually may require assistance from others. The combination of movement problems, poor coordination, and muscle stiffness makes these activities increasingly challenging. Many people find they need to install grab bars in bathrooms, use shower chairs, or modify their clothing to make dressing easier.[15]

Mobility issues have a profound effect on independence. Walking becomes unsteady and unsafe, which means people often need to start using assistive devices like canes or walkers within a few years of symptom onset. This can limit where people can go and what they can do. Driving usually becomes unsafe due to slow reaction times, poor coordination, and the risk of suddenly losing consciousness from blood pressure drops. Losing the ability to drive independently can feel like losing a significant part of one’s freedom and identity.[2]

Communication becomes more challenging as speech problems develop. When words come out slurred, soft, or slow, conversations with family, friends, and even medical providers can become frustrating. Some people feel embarrassed about their speech difficulties and begin to withdraw from social situations. This isolation can worsen feelings of depression and loneliness.[1]

Work life is almost always affected. The combination of physical limitations, fatigue, cognitive changes, and unpredictable symptoms often makes it impossible to continue working, especially in jobs that require physical activity, precise coordination, or consistent attendance. Many people need to reduce their hours, change to less demanding positions, or leave the workforce entirely. This brings not only financial stress but also the loss of professional identity and daily structure.[14]

Hobbies and leisure activities that once brought joy may no longer be possible. Activities requiring fine motor skills, good balance, or sustained physical effort become difficult or impossible. However, it’s important to note that people can often adapt hobbies or find new ones that work within their limitations. For example, someone who loved hiking might shift to enjoying nature through photography from accessible locations, or someone who played guitar might enjoy listening to and analyzing music instead.[15]

Sleep disturbances significantly impact daily life. Many people with multiple system atrophy experience REM sleep behavior disorder, where they physically act out vivid, often violent dreams. This can be dangerous both for the person with the condition and their bed partner. Fragmented sleep, restless legs, and sleep apnea all contribute to poor sleep quality, which leads to severe daytime fatigue and reduced ability to participate in activities.[4]

Emotional and social life undergoes major changes. Dealing with a progressive, fatal illness naturally brings grief, fear, and anxiety. Relationships with partners, family members, and friends shift as roles change and care needs increase. Some relationships grow stronger through the challenge, while others may become strained. Sexual function is often affected both by physical symptoms and by the emotional burden of the disease.[12]

Practical strategies can help manage these challenges. Occupational therapists can provide advice and equipment to help people get around safely and may recommend home modifications. Physical therapists can teach specific exercises that may help prevent falls and maintain mobility for as long as possible. Speech therapists can work on communication strategies and swallowing safety. Registered dietitians can tailor dietary plans to address specific symptoms like constipation or swallowing difficulties.[15]

⚠️ Important
While multiple system atrophy brings many challenges, maintaining quality of life is still possible. A multidisciplinary care team including movement disorder specialists, therapists, dietitians, and social workers can provide comprehensive support. Focusing on abilities rather than limitations, adapting activities to current capabilities, and staying connected with loved ones and support groups can all help maintain dignity and purpose throughout the disease journey.

Supporting Family Members Through Clinical Trials

For families facing multiple system atrophy, clinical trials represent both hope for the future and a potential way to contribute to scientific progress. Understanding what clinical trials involve and how to approach them can help families make informed decisions about participation.[8]

Clinical trials are research studies that test new treatments, diagnostic methods, or approaches to care. While there is currently no cure for multiple system atrophy and no approved disease-modifying therapies, researchers are actively working on various approaches. Some trials focus on therapies targeting alpha-synuclein, the protein that accumulates abnormally in the brain in this disease. Others investigate treatments for neuroinflammation or test cell-based therapies. Still others work on improving symptom management or quality of life.[8][10]

Family members play a crucial role in helping their loved one consider and potentially participate in clinical research. The first step is simply learning what trials are available. Families can ask the patient’s neurologist or movement disorder specialist about ongoing studies. Many medical centers that specialize in movement disorders have research coordinators who can provide information about local trials. Online resources also exist that list clinical trials for multiple system atrophy, though it’s important to discuss any opportunities with the patient’s healthcare team.[15]

When evaluating whether a clinical trial might be appropriate, families should ask several important questions. What is the trial studying? What phase of research is it in? What are the potential benefits and risks? What time commitment is involved? Are there travel requirements? Will there be costs to the patient, or will the trial cover expenses? Understanding these details helps families make informed decisions that align with the patient’s condition, values, and practical circumstances.[8]

It’s important for families to understand that participating in a clinical trial doesn’t guarantee access to a new treatment that will help. Some trials involve placebo groups where participants receive inactive treatment. Even active treatments being studied may not work or may cause side effects. However, all participants contribute valuable information that advances scientific understanding and may help future patients. For many families, this sense of contributing to progress provides meaning and purpose.[10]

Practical support from family members can make trial participation more feasible. This might include providing transportation to study visits, helping track symptoms or medication schedules, accompanying the patient to appointments to help remember information discussed, and providing emotional support through the process. Family members can also help the patient weigh the decision by discussing hopes, concerns, and how trial participation fits with overall goals of care.[15]

Family members should also be aware of the patient’s rights in clinical research. Participation is always voluntary, and patients can withdraw from a trial at any time without affecting their regular medical care. Trials must be approved by ethics committees and follow strict regulations to protect participants. Patients should receive thorough information about the study before agreeing to participate, a process called informed consent.[8]

Beyond individual clinical trials, families can support research in other ways. Some may choose to participate in patient registries or natural history studies that don’t test treatments but collect information about how the disease progresses. Others may wish to discuss brain donation programs, which provide crucial tissue for research after death and can also confirm the diagnosis definitively. While these are personal decisions, they represent additional ways to contribute to the scientific effort to understand and eventually treat multiple system atrophy.[15]

Staying informed about research progress can provide hope and help families feel connected to the broader community working on this disease. Many organizations dedicated to multiple system atrophy provide updates on research findings and clinical trial opportunities. Support groups, both in-person and online, can also be valuable sources of information and shared experiences about clinical trial participation.[12]

💊 Registered drugs used for this disease

While there is currently no cure for multiple system atrophy and no approved disease-modifying therapies, certain medications are used to manage specific symptoms. Based on the sources provided, the following types of drugs may be prescribed:

  • Levodopa – A medication commonly used for Parkinson’s disease that may provide some benefit for movement symptoms in multiple system atrophy, though response is often limited or partial compared to Parkinson’s disease
  • Antiparkinson agents (dopamine agonists) – Medications that mimic dopamine in the brain to help manage parkinsonian symptoms such as slowness and stiffness
  • Midodrine and other agents for orthostatic hypotension – Medications that help raise blood pressure to reduce dizziness and fainting when standing
  • Urinary antispasmodic agents – Medications to help manage bladder control problems such as urgency and frequency

Ongoing Clinical Trials on Multiple system atrophy

  • A Study of Emrusolmin Safety and Effectiveness in Adults with Multiple System Atrophy, a Brain and Nerve Disorder

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Spain
  • Study of Emrusolmin for Treating Adults with Multiple System Atrophy

    Recruiting

    Investigated diseases:
    Investigated drugs:
    France Germany Italy Spain
  • Open-Label Extension Study of ATH434-DP2 in Patients with Multiple System Atrophy

    Not yet recruiting

    1 1
    Investigated diseases:
    France
  • Long-term safety and effectiveness follow-up study of AB-1005 gene therapy in patients with Parkinson’s disease or multiple system atrophy

    Not yet recruiting

    1 1 1
    Poland
  • Study of Amlenetug for Patients with Multiple System Atrophy

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Poland Spain
  • Study on the Effects of TAK-341 for Patients with Multiple System Atrophy

    Not recruiting

    1 1
    Investigated diseases:
    Austria Denmark France Germany Italy Portugal +1
  • Study on the Safety and Tolerability of Exidavnemab in Patients with Mild to Moderate Parkinson’s Disease

    Not recruiting

    Investigated drugs:
    Poland Spain

References

https://www.mayoclinic.org/diseases-conditions/multiple-system-atrophy/symptoms-causes/syc-20356153

https://www.ninds.nih.gov/health-information/disorders/multiple-system-atrophy

https://my.clevelandclinic.org/health/diseases/17250-multiple-system-atrophy

https://neurosciences.ucsd.edu/centers-programs/movement-disorders/community/disease-overview/msa.html

https://emedicine.medscape.com/article/1154583-overview

https://www.massgeneral.org/neurology/treatments-and-services/multiple-system-atrophy

https://www.mayoclinic.org/diseases-conditions/multiple-system-atrophy/diagnosis-treatment/drc-20356157

https://pmc.ncbi.nlm.nih.gov/articles/PMC7851250/

https://my.clevelandclinic.org/health/diseases/17250-multiple-system-atrophy

https://www.delveinsight.com/blog/future-of-multiple-system-atrophy-treatment

https://pmc.ncbi.nlm.nih.gov/articles/PMC6261842/

https://www.nhs.uk/conditions/multiple-system-atrophy/

https://www.e-jmd.org/journal/view.php?doi=10.14802/jmd.22082

https://pspawareness.com/blogs/psp-q-a/living-with-multiple-system-atrophy-tips-and-tricks-for-navigating-daily-life?srsltid=AfmBOoq0wLr7MKYMUwK7-s65TseUN-VSi1Y536ZlK5pUA5iyRMs0vNTy

https://missionmsa.org/living-with-msa/

https://my.clevelandclinic.org/health/diseases/17250-multiple-system-atrophy

https://www.psp.org/iwanttolearn/prime-of-life-brain-disease/msa

https://neurosciences.ucsd.edu/centers-programs/movement-disorders/community/disease-overview/msa.html

https://www.mayoclinic.org/diseases-conditions/multiple-system-atrophy/diagnosis-treatment/drc-20356157

FAQ

How quickly does multiple system atrophy progress?

Multiple system atrophy tends to progress more rapidly than Parkinson’s disease. Most people will require a walking aid such as a cane or walker within a few years after symptoms begin. The median survival from symptom onset is approximately 9 to 10 years, though this varies considerably among individuals depending on symptom severity and which body systems are most affected.

Can multiple system atrophy be inherited or passed to children?

No, multiple system atrophy is considered a sporadic disease, meaning it occurs randomly and is not inherited. There is no evidence that it can be passed on from parents to children. The cause of the disease remains unknown, and researchers are still investigating why some people develop this condition.

Why is multiple system atrophy so hard to diagnose?

The disease is challenging to diagnose because its symptoms overlap significantly with other conditions, particularly Parkinson’s disease. There is no specific blood test or brain imaging test that can definitively diagnose multiple system atrophy, especially in the early stages. Diagnosis relies primarily on clinical assessment by a neurologist familiar with movement disorders, looking at the pattern and combination of symptoms over time.

Will medications for Parkinson’s disease help multiple system atrophy?

Medications like levodopa that work well for Parkinson’s disease may provide some benefit for the movement symptoms of multiple system atrophy, but the response is usually much more limited or partial. Many people with multiple system atrophy experience little to no improvement from these medications, and when they do help, the benefit is often temporary and less dramatic than seen in Parkinson’s disease.

What is the difference between MSA-P and MSA-C?

These are the two main types of multiple system atrophy based on the most prominent symptoms. MSA-P (parkinsonian type) primarily features symptoms similar to Parkinson’s disease, such as slowness of movement, stiffness, and sometimes tremor. MSA-C (cerebellar type) primarily affects coordination and balance, causing unsteady, staggering movements. Both types also involve autonomic nervous system problems like blood pressure and bladder issues.

🎯 Key takeaways

  • Multiple system atrophy is a rare but serious neurodegenerative disease affecting movement, coordination, and automatic body functions, with median survival of about 9 years from symptom onset
  • The disease progresses more rapidly than Parkinson’s disease, and most people will need walking aids within just a few years of diagnosis
  • Falls from sudden blood pressure drops and aspiration pneumonia from swallowing problems are among the most serious and common complications
  • A multidisciplinary care team including neurologists, physical therapists, occupational therapists, speech therapists, and dietitians provides the best symptom management
  • While there is no cure yet, researchers are actively studying treatments targeting abnormal protein accumulation, neuroinflammation, and stem cell therapies
  • Clinical trial participation offers both potential access to experimental treatments and the opportunity to contribute to research that may help future patients
  • The disease was once considered three separate conditions until scientists discovered they shared identical microscopic brain abnormalities
  • Unlike most brain diseases, the abnormal protein clumps in multiple system atrophy form mainly in support cells called oligodendrocytes rather than in neurons themselves